Literature DB >> 21317916

Thymoma and autoimmunity.

Shahar Shelly1, Nancy Agmon-Levin, Arie Altman, Yehuda Shoenfeld.   

Abstract

The thymus is a central lymphatic organ that is responsible for many immunological functions, including the production of mature, functional T cells and the induction of self-tolerance. Benign or malignant tumors may originate from the thymus gland, with thymoma being the most common and accounting for 50% of anterior mediastinal tumors. Malignancies linked to thymoma include the loss of self-tolerance and the presence of autoimmunity. In this review, we compiled the current scientific evidence detailing the various interactions between thymoma and autoimmune diseases, including myasthenia gravis, systemic lupus erythematosus, inappropriate antidiuretic hormone secretion, pure red cell aplasia, pernicious anemia, pemphigus and autoimmune thyroid diseases. In recent years, several mechanisms have been proposed to explain these interactions. Most are based on the assumption that the 'sick' thymus, like the 'normal' thymus, can generate mature T cells; however, the T cells generated by the sick thymus are impaired and thus may exert cellular autoreactivity. Here, we present several theories that may shed light on the loss of self-tolerance associated with this epithelial tumor of the thymus.

Entities:  

Mesh:

Year:  2011        PMID: 21317916      PMCID: PMC4012878          DOI: 10.1038/cmi.2010.74

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  45 in total

Review 1.  Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature.

Authors:  A Boonen; R Rennenberg; S van der Linden
Journal:  Rheumatology (Oxford)       Date:  2000-09       Impact factor: 7.580

2.  Whipple's disease associated with benign thymoma.

Authors:  G B ELLIOTT; M HILL; D L HOWARD
Journal:  Can Med Assoc J       Date:  1961-12-16       Impact factor: 8.262

Review 3.  Lifetime course of myasthenia gravis.

Authors:  David Grob; Norman Brunner; Tatsuji Namba; Murali Pagala
Journal:  Muscle Nerve       Date:  2008-02       Impact factor: 3.217

4.  Paraneoplastic pemphigus regression after thymoma resection.

Authors:  Nikolaos Barbetakis; Georgios Samanidis; Dimitrios Paliouras; Ioannis Boukovinas; Christos Asteriou; Eleni Stergiou; Kostas Laschos; Christodoulos Tsilikas
Journal:  World J Surg Oncol       Date:  2008-08-12       Impact factor: 2.754

5.  Thymic dendritic cells present blood-borne antigens to medullary thymocytes in vivo: a possible role in the generation of the T-cell repertoire.

Authors:  B A Kyewski
Journal:  Haematol Blood Transfus       Date:  1985

Review 6.  The role of T-cells in the initiation of autoantibody responses in thymoma patients.

Authors:  A Vincent; N Willcox
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

Review 7.  Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myasthenia gravis.

Authors:  A C Donadio; K H Dragnev; G K Schwartz
Journal:  South Med J       Date:  1998-03       Impact factor: 0.954

Review 8.  Systemic lupus erythematosus and thymoma--a double-edged sword.

Authors:  G Zandman-Goddard; M Lorber; Y Shoenfeld
Journal:  Int Arch Allergy Immunol       Date:  1995-09       Impact factor: 2.749

9.  [A meta-analysis of thymoma-associated systemic lupus erythematosus from 1975 - 2008 worldwide].

Authors:  Lu Zhang; Jie Dong; Xiao-Mei Leng; Xiao-Feng Zeng
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2009-08

Review 10.  Optimal therapy for thymoma.

Authors:  Kazuya Kondo
Journal:  J Med Invest       Date:  2008-02
View more
  53 in total

1.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

Review 2.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

Review 3.  Thoracoscopic thymectomy in a patient with pemphigus.

Authors:  Ashleigh Xie; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2015-11

Review 4.  Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.

Authors:  Elizabeth A Lippner; David B Lewis; William H Robinson; Tamiko R Katsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-06-22

5.  VATS thymectomy for early stage thymoma and myasthenia gravis: combined right-sided uniportal and left-sided three-portal approach.

Authors:  Maurizio Infante; Cristiano Benato; Riccardo Giovannetti; Cinzia Bonadiman; Barbara Canneto; Giovanni Falezza; Alessandro Lonardoni; Paola Gandini
Journal:  J Vis Surg       Date:  2017-10-18

Review 6.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

7.  Commentary on "Randomized trial of thymectomy in myasthenia gravis".

Authors:  Alexandar Tzankov
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

8.  Acute autoimmune hepatitis, myositis, and myasthenic crisis in a patient with thymoma.

Authors:  Arun Rajan; David Kotlyar; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2013-10       Impact factor: 15.609

9.  Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.

Authors:  Ahmad I Antar; Zaher K Otrock; Mohamed A Kharfan-Dabaja; Rami A Mahfouz; Raafat S Alameddine; Nadim M W El-Majzoub; Ziad M Salem
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

10.  Acute kidney injury associated with thymoma.

Authors:  Zi-Shan Lin; Xi-Zi Zheng; Ai-Bo Qin; Su-Xia Wang; Fu-De Zhou; Ming-Hui Zhao
Journal:  Int Urol Nephrol       Date:  2020-10-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.